Evidence map›Paper›PMID 34070196›Full record

ArticleVaccines2021

The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination-An Analysis of Serological Response and Side Effects.

Chiara Di Resta, Davide Ferrari, Marco Viganò, Matteo Moro, Eleonora Sabetta, Massimo Minerva, Alberto Ambrosio, Massimo Locatelli, Rossella Tomaiuolo

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Safety and efficiency of COVID-19 vaccine in North Africa.Human vaccines & immunotherapeutics · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Self-reported side effects of COVID-19 vaccines among the public.Journal of pharmaceutical policy and practice · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Humoral responses to the CoronoVac vaccine in healthcare workers.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Predictors of seroconversion after coronavirus disease 2019 vaccination.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chiara Di RestaIRCCS San Raffaele Hospital, 20132 Milan, Italy.ORCID 0000-0003-2880-6631
Davide FerrariUniversity of Parma, 43121 Parma, Italy.ORCID 0000-0001-7084-6800
Marco ViganòIRCCS Galeazzi Orthopaedic Institute, 20161 Milan, Italy.ORCID 0000-0002-6463-6564
Matteo MoroIRCCS San Raffaele Hospital, 20132 Milan, Italy.
Eleonora SabettaVita-Salute San Raffaele University, 20132 Milan, Italy.
Massimo MinervaVita-Salute San Raffaele University, 20132 Milan, Italy.
Alberto AmbrosioIRCCS San Raffaele Hospital, 20132 Milan, Italy.
Massimo LocatelliIRCCS San Raffaele Hospital, 20132 Milan, Italy.
Rossella TomaiuoloVita-Salute San Raffaele University, 20132 Milan, Italy.ORCID 0000-0002-2828-782X
Vita-Salute San Raffaele University · ITIstituto Ortopedico Galeazzi · ITUniversity of Parma · IT

Funding

Ministero della Salute COVID-2020-12371619
6 · The paper itself

Abstract

Healthcare professionals are considered to be at high risk of exposure and spread of SARS-CoV-2, and have therefore been considered a priority group in COVID-19 vaccination campaign strategies. However, it must be assumed that the immune response is influenced by numerous factors, including sex and gender. The analysis of these factors is an impact element for stratifying the population and targeting the vaccination strategy. Therefore, a large cohort of healthcare workers participating in the Italian vaccination campaign against SARS-CoV-2 has been studied to establish the impact of sex and gender on vaccination coverage using the Gender Impact Assessment approach. This study shows a significant difference in the antibody titers among different age and sex groups, with a clear decreasing trend in antibody titers in the older age groups. Overall, the serological values were significantly higher in females; the reported side effects are more frequent in females than in males. Therefore, disaggregated data point out how the evaluation of gender factors could be essential in COVID-19 vaccination strategies. On this biomedical and social basis, suggestions are provided to improve the SARS-CoV-2 vaccination campaign in healthcare professionals. Still, they could be adapted to other categories and contexts.

Indexed as

COVID-19gender impact assessmentside effectsvaccination coverage

Identifiers

PMID34070196
PMCPMC8158485
OpenAlexW3162289227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.